The role of therapeutic apheresis in the management of IBD

The main objectives of this webinar are: clarify what is needed to have the best treatment outcome for IBD patients, how to help them maintain control of their disease and how Adacolumn’s mechanism of action might contribute to achieving both, alone or in combination with other therapies. Dr. Alessandro Mazzoni. (H. Dr. Peset) Dra. Irene […]

Source vidéo: La Lettre de L’Hépato Gastroentérologue, EDIMARK France.

Source vidéo: La Lettre de L’Hépato Gastroentérologue, EDIMARK France.

The paediatric inflammatory bowel disease (IBD) can cause malnutrition and growth retardation. Patients with IBD will require life-long treatment but can be limited by the potential adverse events of corticosteroids and anti-TNF agents in children as well as secondary loss of response (LoR) and drug dependence can occur at some time during the lifetime. Experience […]

Source vidéo: La Lettre de L’Hépato Gastroentérologue, EDIMARK France.

Unique considerations when treating children and adolescents with IBD include attention to the effects and risks of the treatments on growth and development, bone health, and psychosocial functioning. New alternatives of treatment still are needed in this context for safer and longer outcomes. The benefits of using steroids, immunosuppressants or biologics need to be carefully […]

While there is no known cure for ulcerative colitis and flare ups may recur, optimal treatment option can help patient stay in control of their disease and lead a full and rewarding life. The primary goal in treating ulcerative colitis is to help patients regulate their immune system better. Nevertheless, current approved treatments don’t work […]